DevicePharm VP Christine Horton was a featured participant in a panel focused on leading and negotiating at “Women’s Executive Network Leadership Conference” sponsored by AdvaMed.

DevicePharm VP in Women’s Leadership Conference

By Articles, Medical Device Marketing

On June 20, 2017, DevicePharm was represented with a featured group of business leaders in the “Women’s Executive Network Leadership Conference” sponsored by AdvaMed. The event, held in Boston, included an amazing group of medical device leaders. The attendance, which set a new event record, included participants ranging from large medical device organizations to emerging tech companies.

Read More
Christine Horton in the Austin, TX office

DevicePharm Opens Austin, TX Office

By Articles, Biotech Marketing

On May 1, 2017, DevicePharm announced the opening of our new office in Austin, Texas. This office was developed to serve the growing medical technology industry in Austin, Houston, Dallas, and San Antonio.

Clay Wilemon, DevicePharm CEO and Chief Strategy Officer described the motivation for opening the Austin office, “Texas has over 700 medical device, biotech, diagnostics, and pharmaceutical companies.

Read More
Sonex Health micro-invasive carpel tunnel release - medical device marketing materials

Sonex Health Completes First Surgery for Micro-Invasive Treatment of Carpal Tunnel Syndrome

By Medical Device Marketing, Press

On February 22, 2017, Sonex Health announced the successful completion of the first ultrasound-guided carpal tunnel release procedure in the United States using the SX-One MicroKnife™. The SX-One MicroKnife™ is an ultra-low profile surgical device that allows physicians to perform Micro-invasive carpal tunnel release (CTR) surgery through a single micro-incision (4-5 mm) using ultrasound guidance.

Read More
7D Surgical promotional materials

7D Surgical Announces Regulatory Milestones

By Medical Device Marketing, Press Release

7D Surgical announced today that it has received both 510(k) clearance from the U.S. Food and Drug Administration (FDA) and a medical device license from Health Canada enabling the North American commercial launch of its innovative Machine-vision Image Guided Surgery (MIGS™) system for spine surgery, the 7D Surgical System. This breakthrough system is designed to simplify and speed up surgical workflow, increase surgeon control, eliminate intraoperative radiation, and deliver exceptional value.

Read More